Press release
Dengue Vaccine Market Report Analysis, Research Studies | Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/dengue-vaccine-market
The Dengue Vaccine market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
The Dengue Vaccine Market refers to the global industry focused on the research, development, production, and distribution of vaccines designed to prevent dengue fever, a mosquito-borne viral infection caused by the dengue virus. This market includes vaccines targeting multiple serotypes of the dengue virus, which can cause severe flu-like symptoms and, in some cases, lead to life-threatening complications such as dengue hemorrhagic fever or dengue shock syndrome. The market is driven by the global burden of dengue, particularly in tropical and subtropical regions, and efforts to reduce transmission through vaccination programs. Key players in this market include pharmaceutical companies, research institutions, and public health organizations working towards effective prevention strategies against dengue fever.
Forecast Growth Projected:
The Global Dengue Vaccine Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Dengue Vaccine Market:
Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd, Vabiotec, Panacea Biotec and Medigen Biologics.
Segment Covered in the Dengue Vaccine Market:
By Product Type: CYD-TDV
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others
Regional Analysis:
The global Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/dengue-vaccine-market
Regional Analysis:
The global Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Dengue Vaccine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Dengue Vaccine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Dengue Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/dengue-vaccine-market
FAQs
How fast is the Dengue Vaccine Market growing?
The Dengue Vaccine Market will exhibit a CAGR of 10.4% during the forecast period, 2024-2031.
Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Vaccine Market Report Analysis, Research Studies | Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd here
News-ID: 3573377 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
PBSA Market Poised to Hit USD 730 Billion by 2031 | Bags Alone Drive 35% of Glob …
PBSA Market Size & Growth
The global PBSA market is witnessing substantial growth, driven by increasing demand for biodegradable plastics, rising consumer preference for sustainable packaging, and expanding applications across textiles, food & beverage, and retail sectors. The market was valued at approximately USD 450 million in 2023 and is projected to reach around USD 730 million by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the…
United States Precision Stainless Steel Market 2025 | Growth Drivers, Key Player …
Market Size and Growth
The Precision Stainless Steel Market is estimated to be valued at USD 2.8 billion in 2025 and is projected to reach USD 4.2 billion by 2035, registering a compound annual growth rate (CAGR) of 4.5% over the forecast period.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/precision-stainless-steel-market?sb
Key Development:
United States:
✅ In November 2025, U.S. Steel announced a $75 million investment…
PBSA Market Poised to Hit USD 730 Billion by 2031 | Bags Alone Drive 35% of Glob …
PBSA Market Size & Growth
The global PBSA market is witnessing substantial growth, driven by increasing demand for biodegradable plastics, rising consumer preference for sustainable packaging, and expanding applications across textiles, food & beverage, and retail sectors. The market was valued at approximately USD 450 million in 2023 and is projected to reach around USD 730 million by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the…
United States Skin Cancer Drugs Market 2025 | Growth Drivers, Key Players & Inve …
Market Size and Growth
Skin Cancer Drugs Market is estimated to reach high CAGR of 10.2% during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/skin-cancer-drugs-market?sb
Key Development:
United States: Recent Skin Cancer Drug Developments
✅ In November 2025, Unloxcyt (cosibelimab‐ipdl) had its label expanded by the U.S. Food and Drug Administration (FDA) to include adults with metastatic…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
